[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100454272":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":25,"locations":34,"responsibleParty":53,"collaborators":55,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":68,"acronym":69,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":18,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":83,"overallStatus":37,"whyStopped":18,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Procedure","Baseline low dose Ct acquisition, then at 1 year and 2 years to depict suspicious lung nodules",[12],"Procedure: Low-dose computed tomography of the chest",[14],{"type":15,"name":16,"description":10,"armGroupLabels":17,"otherNames":18},"PROCEDURE","Low-dose computed tomography of the chest",[9],null,[20,23],{"name":21,"affiliation":5,"role":22},"Marie-Pierre REVEL, PhD","PRINCIPAL_INVESTIGATOR",{"name":24,"affiliation":5,"role":22},"Marie WISLEZ, PhD",[26,30],{"name":21,"role":27,"phone":28,"phoneExt":18,"email":29},"CONTACT","+33 1 42 34 79 10","marie-pierre.revel@aphp.fr",{"name":31,"role":27,"phone":32,"phoneExt":18,"email":33},"Adèle BELLINO, MS","+33 1 58 41 11 95","adele.bellino@aphp.fr",[35],{"facility":36,"status":37,"city":38,"state":18,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Hôtel-Dieu","RECRUITING","Paris","75004","France","FR",{"type":43,"coordinates":44},"Point",[45,46],2.3488,48.85341,{"lat":46,"lon":45},[49,50],{"name":21,"role":27,"phone":28,"phoneExt":18,"email":29},{"name":24,"role":27,"phone":51,"phoneExt":18,"email":52},"+33 1 58 41 19 06","marie.wislez@aphp.fr",{"type":54,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[56,59,62],{"name":57,"class":58},"Ministère de la Santé et des Solidarités","UNKNOWN",{"name":60,"class":61},"National Cancer Institute, France","OTHER_GOV",{"name":63,"class":6},"URC-CIC Paris Descartes Necker Cochin","100454272","lung-cancer-screening-with-low-dose-ct-scan-in-women--implementation-study-100454272",false,"NCT05195385","Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study","CASCADE","Inclusion Criteria:\n\n* Women aged from 50 to 74 years\n* who had smoked at least 20 pack years and quit less than 15 years ago\n* Had given their consent and accepted the need for a 2-year follow-up\n* Affiliated to the social security system\n\nExclusion Criteria\n\n* Presence of clinical symptoms suggesting malignancy (weight loss, hemoptysis) or ongoing infection (cough with fever)\n* Evolving cancer\n* History of lung cancer\n* A 2-year follow-up not possible\n* Chest CT scan performed within 2 years prior to inclusion","FEMALE","50 Years","74 Years",{"count":75,"type":76},2635,"ESTIMATED","INTERVENTIONAL",[79],"NA","The purpose of this study is to determine whether reading of low-dose thoracic CT scans can be done by a single general radiologist who has been trained to lung cancer screening, and will evaluate the performance in comparison with double reading by experts.\n\nThe study will enroll women between 50 and 74 years old, at risk for lung cancer due to their smoking history.",[82],"Lung Cancer Screening",[84,85,86,87,88],"lung neoplasms","multidetector computed tomography","early detection of cancer","artificial intelligence","lung cancer screening","2026-03-25",{"date":91,"type":92},"2026-03-30","ACTUAL",{"date":94,"type":92},"2022-04-08",{"date":96,"type":76},"2027-10-08",{"name":5,"class":6},1]